The Clinical Significance of miR-21 in Guiding Chemotherapy for Patients with Osteosarcoma

References

• Geller DS, Gorlick R. Osteosarcoma: a review of diagnosis, management, and treatment strategies. Clin Adv Hematol Oncol. 2010;8(10):705–718.
   PubMedGoogle Scholar
• Ottaviani G, Jaffe N. The epidemiology of osteosarcoma. Cancer Treat Res. 2009;152:3–13.
   PubMedGoogle Scholar
• Sun K, Wang W, Zeng JJ, et al. Micro RNA-221 inhibits CDKN1C/p57 expression in human colorectal carcinoma. Acta Pharmacol Sin. 2011;32(3):375–384. doi:10.1038/aps.2010.206
   Web of Science ®Google Scholar
• Hameed M, Doffman H. Primary malignant bone tumors-recent developments. Semin Diagn Pathol. 2011;28(1):86–101. doi:10.1053/j.semdp.2011.02.002
   PubMed Web of Science ®Google Scholar
• Sielari VA, Qin L. Targeting the osteosarcoma cancer stem cell. J Orthop Surg Res. 2010;5:78. doi:10.1186/1749-799X-5-78
   Web of Science ®Google Scholar
• Steinmann P, Walters DK, Arlt MJ, et al. Antimetastatic activity of honokiol in osteosarcoma. J Cancer. 2012;118(8):2117–2127. doi:10.1002/cncr.26434
   Web of Science ®Google Scholar
• Broadhead ML, Clark JC, Myers DE, Dass CR, Choong PF. The molecular pathogenesis of osteosarcoma: a review. Sarcoma. 2011;2011:959248. doi:10.1155/2011/959248
   PubMedGoogle Scholar
• Zheng W, Zhao J, Tao Y, et al. MicroRNA-21: a promising biomarker for the prognosis and diagnosis of non-small cell lung cancer. Oncol Lett. 2018;16:2777–2782.
   Web of Science ®Google Scholar
• Lopezanton M, Lambie M, Lopezcabrera M, et al. miR-21 Promotes Fibrogenesis in Peritoneal Dialysis. Am J Pathol. 2017;187:1537. doi:10.1016/j.ajpath.2017.03.007
   Web of Science ®Google Scholar
• Li C, Xu B, Miu X, Deng Z. Inhibition of miRNA-21 attenuates the proliferation and metastasis of human osteosarcoma by upregulating PTEN. Exp Ther Med. 2018;15:1036–1040.
   PubMed Web of Science ®Google Scholar
• Hu X, Li L, Lu Y, Yu X, Chen H. miRNA-21 inhibition inhibits osteosarcoma cell proliferation by targeting PTEN and regulating the TGF-β1 signaling pathway. Oncol Lett. 2018;16:4337–4342.
   PubMed Web of Science ®Google Scholar
• Di Leva G, Croce CM. Roles of small RNAs in tumor formation.Trends. Mol Med. 2010;16(6):257‐267.
   Web of Science ®Google Scholar
• Esteller M. Non‐coding RNAs in human disease. Nat Rev Genet. 2011;12(12):861‐874. doi:10.1038/nrg3074
   Web of Science ®Google Scholar
• Garofalo M, Croce CM. MicroRNAs as therapeutic targets in chemoresistance. Drug Resist Updates. 2013;16(3–5):47‐59. doi:10.1016/j.drup.2013.05.001
   Web of Science ®Google Scholar
• Lee JW, Kim N, Park JH, et al. Differential microRNA expression between gastric cancer tissue and non‐cancerous gastric mucosa according to Helicobacter pylori status. J C a n C e r P r e. 2017;22(1):33‐39.
   Google Scholar
• Song B, Wang Y, Xi Y, et al. Mechanism of chemoresistance mediated by miR‐140 in human osteosarcoma and colon cancer cells. Oncogene. 2009;28(46):4065‐4074. doi:10.1038/onc.2009.274
   Web of Science ®Google Scholar
• Gougelet A, Pissaloux D, Besse A, et al. Micro‐RNA profiles in osteosarcoma as a predictive tool for ifosfamide response. Int JCancer. 2011;129(3):680‐690.
   Web of Science ®Google Scholar
• Dong Y, Yu J, Ng SS. MicroRNA dysregulation as a prognostic biomarker in colorectal cancer. Cancer Manag Res. 2014;6(3):405–422.
   Google Scholar
• Calin GA, Dumitru CD, Shimizum, et al. Frequent deletions and down regulation of microRNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA. 2002;99(24):15524–15529. doi:10.1073/pnas.242606799
   PubMed Web of Science ®Google Scholar
• Qi P, Gao CF. Study progress of miRNA in hepatocytes. China Biotechnol. 2008;28(12):94–101.
   Google Scholar
• Kinet V, Halkein J, Dirkx E, Windt LJ. Cardiovascular extracellular microRNAs: emerging diagnostic markers and mechanisms of cell-to-cell RNA communication. Front Genet. 2013;12(4):214.
   Google Scholar
• Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA. 2008;105(30):10513–10518. doi:10.1073/pnas.0804549105
   PubMed Web of Science ®Google Scholar
• Ma R, Jiang T, Kang X. Circulating microRNAs in cancer: origin, function and application. J Exp Clin Cancer Res. 2012;31(1):38. doi:10.1186/1756-9966-31-38
   Web of Science ®Google Scholar
• Ziyan W, Shuhua Y, Xiufang W, Xiaoyun L. MicroRNA-21 is involved in osteosarcoma cell invasion and migration. Med Oncol. 2011;28(4):1469–1474. doi:10.1007/s12032-010-9563-7
   PubMed Web of Science ®Google Scholar
• Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009;19:92–105. doi:10.1101/gr.082701.108
   PubMed Web of Science ®Google Scholar
• Miranda KC, Huynh T, Tay Y, et al. A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell. 2006;126(6):1203–1217. doi:10.1016/j.cell.2006.07.031
   PubMed Web of Science ®Google Scholar
• Ouyang L, Liu P, Yang S, Ye S, Xu W, Liu X. A three-plasma miRNA signature serves as novel biomarkers for osteosarcoma. Med Oncol. 2013;30(1):340. doi:10.1007/s12032-012-0340-7
   PubMed Web of Science ®Google Scholar
• Namløs HM, Meza-Zepeda LA, Barøy T, et al. Modulation of the osteosarcoma expression phenotype by microRNAs. PLoS One. 2012;7(10):e48086.
   PubMed Web of Science ®Google Scholar
• Vanas V, Haigl B, Stockhammer V, Sutterlüty-Fall H. MicroRNA-21 Increases Proliferation and Cisplatin Sensitivity of Osteosarcoma-Derived Cells. PLoS One. 2016;11(8):e0161023.
   Web of Science ®Google Scholar
• Qu K, Lin T, Pang Q, et al. Extracellular miRNA-21 as a novel biomarker in glioma: evidence from meta-analysis, clinical validation and experimental investigations. Oncotarget. 2016;7(23):33994–34010. doi:10.18632/oncotarget.9188
   PubMedGoogle Scholar
• Gong B, Liu WW, Nie WJ, et al. MiR-21/RASA1 axis affects malignancy of colon cancer cells via RAS pathways. World J Gastroenterol. 2015;21(5):1488–1497. doi:10.3748/wjg.v21.i5.1488
   PubMed Web of Science ®Google Scholar
• Yamanaka S, Olaru AV, An F, et al. MicroRNA-21 inhibits Serpini1, a gene with novel tumour suppressive effects in gastric cancer. Dig Liver Dis. 2012;44(7):589–596. doi:10.1016/j.dld.2012.02.016
   Google Scholar
• Zadeh MM, Ranji N, Motamed N. Deregulation of miR-21 and miR-155 and their putative targets after silibinin treatment in T47D breast cancer cells. Iran J Basic Med Sci. 2015;18(12):1209–1214.
   PubMed Web of Science ®Google Scholar
• Hua Y, Jin Z, Zhou F, et al. The expression significance of serum MiR-21 in patients with osteosarcoma and its relationship with chemosensitivity. Eur Rev Med Pharmacol Sci. 2017;21:2989–2994.
   PubMed Web of Science ®Google Scholar
• Zhang R, Xia T. Long non-coding RNA XIST regulates PDCD4 expression by interacting with miR-21-5p and inhibits osteosarcoma cell growth and metastasis. Int J Oncol. 2017;51(5):1460–1470. doi:10.3892/ijo.2017.4127
   PubMed Web of Science ®Google Scholar
• Wu ZY, Liu Y, Yang SH. The significance of serum microRNA-21 expression and its sensitivity to chemotherapeutic drugs in osteosarcoma patients. J Pract Orthop. 2015;21(7):607–610.
   Google Scholar
• Jing YL, Lv Z. Research progress of microRNA in osteosarcoma. Cancer Res Clin. 2016;28(9):638–641.
   Google Scholar
• Graziano AC, Cardile V, Avola R, Vicario N, Parenti C, Salvatorelli L. Wilms’ tumor gene 1 silencing inhibits proliferation of human osteosarcoma MG-63 cell line by cell cycle arrest and apoptosis activation. Oncotarget. 2017;8:13917–13931. doi:10.18632/oncotarget.14715
   Google Scholar
• Wang L, Tang B, Han H, Mao D, Chen J. miR-155 Affects Osteosarcoma MG-63 Cell Autophagy Induced by Adriamycin Through Regulating PTEN-PI3K/AKT/mTOR Signaling Pathway. Cancer Biother Radiopharm. 2018;33:32‑38. doi:10.1089/cbr.2017.2306
   Web of Science ®Google Scholar
• Zhang J, Yu XH, Yan YG. PI3K/Akt signaling in osteosarcoma. Clin Chim Acta. 2015;444:182–192. doi:10.1016/j.cca.2014.12.041
   PubMed Web of Science ®Google Scholar
• Wu YR, Qi HJ, Deng DF, Luo YY, Yang SL. MicroRNA-21 promotes cell proliferation, migration, and resistance to apoptosis through PTEN/PI3K/AKT signaling pathway in esophageal cancer. Tumour Biol. 2016;37:12061‑12070. doi:10.1007/s13277-016-5074-2
   Google Scholar
• Xue R, Lei S, Xia ZY, et al. Selective inhibition of PTEN preserves ischaemic post-conditioning cardioprotection in STZ-induced Type 1 diabetic rats: role of the PI3K/Akt and JAK2/STAT3 pathways. Clin Sci (Lond). 2016;130:377–392. doi:10.1042/CS20150496
   PubMed Web of Science ®Google Scholar
• Pfeffer SR, Yang CH, Pfeffer LM. The Role of miR‐21 in Cancer. Drug Dev Res. 2015;76(6):270‐277. doi:10.1002/ddr.21257
   Web of Science ®Google Scholar
• Ziyan W, Yang L. MicroRNA‐21 regulates the sensitivity to cisplatin in a human osteosarcoma cell line. Ir J Med Sci. 2016;185(1):85‐91. doi:10.1007/s11845-014-1225-x
   Web of Science ®Google Scholar